drugset / Trial / NCT02251158
Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study to determine the relative bioavailability of 500/200 mg of tipranavir/ritonavir (TPV/r) oral solution compared to 500/200 mg of TPV/r capsules following oral administration and to investigate the relative bioavailability of 500/200 mg of TPV/r oral solution with food versus without food.
Timeline
- Start
- 2003-10
- Primary completion
- 2003-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritonavir | Other / unclassified | 200 mg | Oral |
| Subject | Tipranavir | Small molecule | 500 mg | Oral |
Indications
No indication recorded.